Kairos Pharma

Performance

About Kairos Pharma

Kairos Pharma is a clinical-stage biopharmaceutical company focused on oncology, developing novel therapies to reverse cancer drug resistance and counter cancer-induced immune suppression. The company pursues immuno-oncology approaches, aiming to restore anti-tumor immune responses and enhance the efficacy of existing cancer drugs. Its pipeline includes antibody- and small molecule–based strategies such as ENV105 and other technologies designed to address resistance mechanisms across multiple cancer types, including prostate cancer, lung cancer, and glioblastoma.